Matinas BioPharma Holdings, Inc.
MTNB
$0.59
-$0.05-7.84%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 57.34% | 20.19% | 14.42% | 13.63% | -5.71% |
| Total Depreciation and Amortization | -53.09% | -36.99% | -22.73% | -9.66% | 3.29% |
| Total Amortization of Deferred Charges | -- | -- | -- | 30.77% | -- |
| Total Other Non-Cash Items | -41.69% | 99.93% | 104.97% | 37.08% | 48.83% |
| Change in Net Operating Assets | -1,052.67% | -18.68% | -241.54% | -3.57% | -107.86% |
| Cash from Operations | 55.86% | 46.84% | 38.24% | 28.52% | -3.97% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -95.71% | 224.98% | -42.15% | -31.59% |
| Cash from Investing | -96.36% | -92.97% | 226.66% | -41.12% | -30.46% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -80.00% | 40.00% | -25.00% | -25.00% | 28.57% |
| Issuance of Common Stock | -98.60% | -99.31% | -100.00% | 16,918.52% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -63.04% | -63.68% | -65.36% | 21,436.00% | 131,157.14% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -231.56% | -225.00% | 141.78% | 225.39% | 222.22% |